Moolec Science (MLECW) Common Equity (2022 - 2026)

Moolec Science has reported Common Equity for 5 years, with the latest figure at $11.3 million in Q1 2026.

• Quarterly Common Equity changed N/A year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (changed N/A YoY) and the FY2025 annual result came in at -$67.4 million, down 126.98% from the prior year.
• Common Equity grew to $11.3 million in Q1 2026 per MLECW's latest filing, from $9.2 million in the prior quarter.
• Over five years, Common Equity peaked at $258.6 million in Q2 2023 and troughed at -$67.4 million in Q2 2025.
• A 5-year average of $42.4 million and a median of $6.7 million in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2023 and 2025: Common Equity surged 907.08% in 2023, then slumped 126.98% in 2025.
• Over 5 years, Common Equity stood at $11.9 million in 2022, then slumped by 43.82% to $6.7 million in 2023, then sank by 58.16% to $2.8 million in 2024, then jumped by 229.56% to $9.2 million in 2025, then grew by 22.61% to $11.3 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $11.3 million, $9.2 million, and -$67.4 million for Q1 2026, Q4 2025, and Q2 2025 respectively.